Clinical Trials Browser

Phase 3 × Recruiting × anlotinib × Clear all

NCT07443397 2026-03-02

Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.

Phase 3 Recruiting

Whole-Brain Radiotherapy

NCT06043973 2023-09-21

Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

Phase 3 Recruiting

Advanced Non-small Cell Lung Cancer